Imcheck Therapeutics raised €96M in a funding round in Jun 2022. The company is based in Marseille, France. Investors in the round: Andera Partners, Earlybird, Invus fund and 1 other. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €96M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
